Filing Details

Accession Number:
0001209191-21-014542
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-25 20:51:15
Reporting Period:
2021-02-23
Accepted Time:
2021-02-25 20:51:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Outlook Therapeutics Inc. OTLK Biological Products, (No Disgnostic Substances) (2836) 383982704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760510 Terry Dagnon C/O Outlook Therapeutics, Inc.
4260 Us Route 1
Monmouth Junction NJ 08852
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-23 15,900 $2.09 1,127,857 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.